Monsanto

Monsanto
Name	Monsanto Company
Fate	Acquired by Bayer AG (2018)
Founded	1901
Founder	John Francis Queeny
Defunct	2018 (brand retired)
Headquarters	St. Louis
Industry	Chemical industry, Agriculture
Products	Glyphosate, Polychlorinated biphenyl, Genetically modified seeds

Monsanto Monsanto was an American agrochemical and agricultural biotechnology corporation founded in 1901 by John Francis Queeny in St. Louis. Over its history it became prominent for commercializing glyphosate-based herbicides and genetically engineered seeds, and later became a focal point in debates involving environmentalism, biotechnology, and intellectual property rights. Monsanto’s corporate trajectory culminated in a 2018 acquisition by Bayer AG, after which the Monsanto name was retired.

History

Monsanto originated in 1901 as a chemical firm producing saccharin for the food industry, later expanding into industrial chemicals such as polychlorinated biphenyls in the early 20th century. During the mid-20th century the company diversified into agrochemicals and pharmaceuticals, developing products tied to the World War II and postwar industrial boom. In the 1970s and 1980s Monsantoshifted toward agriculture, acquiring seed companies and investing in biotechnology research linked to institutions like Monsanto Chemical Company's collaborations with academic laboratories and Cold Spring Harbor Laboratory-era molecular biology advances. The 1990s saw commercialization of genetically modified crops following regulatory approvals influenced by frameworks established after the Reagan administration's deregulatory policies and United States Department of Agriculture guidance. The 2000s brought consolidation in the agribusiness sector through mergers and acquisitions, culminating in the 2016 proposed merger with Bayer AG and the completed acquisition in 2018 amid global antitrust review by bodies including the European Commission and the United States Department of Justice.

Products and Technologies

Monsanto’s product portfolio historically included herbicides, seeds, and biotechnology platforms. The most widely known herbicide was formulated with glyphosate, marketed under the trade name Roundup (trade names not linked), used on crops engineered to be glyphosate-tolerant via transgenic events such as Roundup Ready technology. Seed offerings encompassed genetically modified varieties of soybean, maize, cotton, and canola, incorporating traits for herbicide tolerance and insect resistance via Bacillus thuringiensis-derived Cry proteins. Monsanto invested in molecular breeding platforms and trait licensing, negotiating technology agreements with multinational firms like DuPont and Syngenta. The company also developed proprietary seed technologies including terminator technology-related research debates and platforms for marker-assisted selection used in collaborations with research institutes such as Iowa State University and University of Illinois.

Controversies and Legal Issues

Monsanto was central to numerous controversies and legal disputes involving pesticide residues, patent enforcement, and litigation over herbicide-cancer claims. High-profile lawsuits were filed in jurisdictions including California and France, with plaintiffs alleging links between glyphosate exposure and non-Hodgkin lymphoma, leading to jury verdicts and appeals under laws guided by the Federal Insecticide, Fungicide, and Rodenticide Act and state tort statutes. Patent enforcement actions targeted farmers and seed companies, invoking intellectual property rights under United States patent law and prompting disputes before courts such as the United States Court of Appeals for the Federal Circuit. Antitrust scrutiny during proposed mergers involved regulators like the European Commission and the United States Department of Justice, concerned with market concentration among firms including Bayer AG, Dow Chemical Company, and BASF. Activist campaigns against corporate practices mobilized NGOs such as Greenpeace and Friends of the Earth, and public protests occurred in locations like India and Brazil over seed pricing and farmer dependency.

Corporate Structure and Ownership

Throughout its history Monsanto operated as a publicly traded company listed on exchanges overseen by Securities and Exchange Commission regulations until acquisition negotiations with Bayer AG were announced in 2016. Corporate governance involved boards of directors with executives who previously served at multinational firms such as DuPont and Pfizer, and partnerships with research organizations including The Rockefeller Foundation and academic centers. Ownership shifted through strategic divestitures, spin-offs, and acquisitions; notable transactions included the sale of its pharmaceutical assets and consolidation of seed and trait portfolios. The acquisition by Bayer AG required divestitures to companies like BASF and DowDuPont-era entities to obtain regulatory clearance.

Environmental and Health Impact Studies

Monsanto and independent researchers produced extensive literature assessing environmental and health impacts of herbicides and transgenic crops. Regulatory agencies including the Environmental Protection Agency and the European Food Safety Authority evaluated glyphosate’s toxicology, with reviews citing epidemiological studies, animal bioassays, and mechanistic research. Meta-analyses and cohort studies published in journals drew scrutiny from institutions such as World Health Organization agencies and prompted differing classifications by bodies like the International Agency for Research on Cancer. Environmental impact assessments examined effects on biodiversity in regions such as the Midwestern United States and Argentina, addressing concerns about herbicide use, development of glyphosate-resistant weeds, and changes in tillage practices influenced by herbicide-tolerant cropping systems.

Economic and Agricultural Impact

Monsanto’s technologies altered planting practices, seed markets, and input costs across major agricultural regions including the United States Corn Belt, Brazilian cerrado, and Argentina Pampas. Adoption of herbicide-tolerant and insect-resistant varieties affected yields, herbicide application patterns, and farmer profitability analyzed by economists at institutions like USDA Economic Research Service and International Food Policy Research Institute. Monsanto’s intellectual property regime influenced seed industry structure, generating licensing revenues and prompting policy debates within bodies such as the World Trade Organization and national legislatures over seed saving and patent scope. The company’s role in consolidation among multinationals reshaped global supply chains involving agribusiness firms including Cargill and Archer Daniels Midland.

Category:Biotechnology companies